Literature DB >> 16442178

Lipopolysaccharides-activated human astroglioma cells induce apoptotic death of T-lymphocytes via c-Jun N-terminal kinases-dependent up-regulation of TRAIL.

Daeho Kwon1, Jae Hoon Cheong, Jae-Chul Lee, Jae-Hyun Kwon, Won-Ki Kim.   

Abstract

In the present study, we report that activated human astroglioma cells can injure T-lymphocytes by producing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). Treatment with lipopolysaccharides (LPS), a well-known immune stimulator, increased the expression levels of TRAIL mRNA and protein in human astroglioma cells. The increase of TRAIL mRNA expression by LPS was preceded by phosphorylation of the c-Jun N-terminal kinase (JNK) and consequently abrogated in the presence of the specific JNK inhibitor SP600125. The up-regulation of TRAIL expression was well co-related with AP-1 activation. Activated human astroglioma cells markedly induced the apoptotic death of T-lymphocytes. Pre-treatment with the TRAIL antagonistic protein TRAIL-R2:Fc prevented the death of T-lymphocytes caused by activated human astroglioma cells. The present results suggest that astroglioma cells may down-regulate T-lymphocytes via up-regulation of TRAIL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442178     DOI: 10.1016/j.neures.2005.12.011

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  2 in total

1.  Heat-Labile Enterotoxin-Induced PERK-CHOP Pathway Activation Causes Intestinal Epithelial Cell Apoptosis.

Authors:  Xi Lu; Chunmeng Li; Congcong Li; Pengcheng Li; Enqing Fu; Yonghong Xie; Faguang Jin
Journal:  Front Cell Infect Microbiol       Date:  2017-06-08       Impact factor: 5.293

2.  MiR-98 Protects Nucleus Pulposus Cells against Apoptosis by Targeting TRAIL in Cervical Intervertebral Disc Degeneration.

Authors:  Shimin Xu; Yuezhong Li; Junshan Zhang; Zhiwei Li; Yanping Xing
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.